MAPESBURY MEDICAL GROUP — All Prescriptions & Medications — Page 7
Practice Code: E84012 | LONDON, NW2 3PS
Showing results 301-350 of 544
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Isosorbide dinitrate | 49 | 728 | £54 | +172.5% ▲ |
| Travoprost | 49 | 198 | £180 | +4.0% ▲ |
| 48 | 16.4K | £770 | -52.7% ▼ | |
| Alprostadil | 47 | 318 | £3.6K | +174.8% ▲ |
| Metoclopramide hydrochloride | 46 | 1,946 | £71 | -44.5% ▼ |
| Cetomacrogol | 46 | 23.0K | £162 | +59.2% ▲ |
| 45 | 4,740 | £323 | -35.5% ▼ | |
| Zinc oxide | 44 | 2,136 | £293 | +112.7% ▲ |
| Carvedilol | 44 | 3,304 | £92 | -61.2% ▼ |
| Ursodeoxycholic acid | 43 | 5,932 | £1.1K | -35.0% ▼ |
| Alfuzosin hydrochloride | 43 | 1,716 | £511 | -39.9% ▼ |
| Chlorhexidine gluconate | 43 | 17.9K | £151 | +95.8% ▲ |
| Hydrocortisone acetate | 43 | 1,290 | £246 | -34.9% ▼ |
| 43 | 990 | £642 | -0.3% vs avg | |
| Fosfomycin trometamol | 42 | 59 | £273 | +47.6% ▲ |
| Lidocaine hydrochloride | 42 | 1,155 | £1.8K | -75.7% ▼ |
| Other toiletry preparations | 42 | 18.5K | £202 | -1.7% vs avg |
| 41 | 2,111 | £5.2K | +2.8% ▲ | |
| Permethrin | 40 | 4,110 | £1.2K | +6.2% ▲ |
| Glucose | 39 | 4,590 | £403 | -25.0% ▼ |
| Medroxyprogesterone acetate | 39 | 3,674 | £839 | +1.9% vs avg |
| Powder extensively hydrolysed formula (0913101) | 39 | 93.6K | £2.7K | -45.9% ▼ |
| 39 | 1,865 | £2.1K | +5.1% ▲ | |
| Tamoxifen citrate | 38 | 1,914 | £158 | -53.9% ▼ |
| Diethylamine salicylate | 38 | 3,000 | £93 | +40.8% ▲ |
| Losartan potassium with diuretic | 36 | 1,932 | £267 | +40.4% ▲ |
| Amisulpride | 36 | 1,596 | £695 | -48.8% ▼ |
| Fludrocortisone acetate | 36 | 694 | £97 | -65.9% ▼ |
| 36 | 531 | £428 | -2.8% ▼ | |
| Oral rehydration salts | 35 | 516 | £220 | +21.1% ▲ |
| Timolol | 35 | 1,450 | £356 | -60.4% ▼ |
| Light liquid paraffin | 35 | 26.5K | £506 | +2.8% ▲ |
| 35 | 35 | £151 | -31.8% ▼ | |
| Moxonidine | 34 | 700 | £118 | -38.9% ▼ |
| Fluticasone/umeclidinium/vilanterol | 34 | 34 | £1.4K | -85.5% ▼ |
| Hydrocortisone | 33 | 3,432 | £189 | -60.9% ▼ |
| 33 | 294 | £219 | +6.0% ▲ | |
| Umeclidinium bromide | 32 | 32 | £836 | -48.1% ▼ |
| Tolterodine | 32 | 1,680 | £143 | -78.5% ▼ |
| Piroxicam | 32 | 2,180 | £57 | -44.3% ▼ |
| Heparinoid | 32 | 4,125 | £226 | +22.0% ▲ |
| Betamethasone sodium phosphate | 32 | 530 | £117 | +23.5% ▲ |
| Other individually formulated bought in preparations | 32 | 1,760 | £234 | -2.1% ▼ |
| 32 | 720 | £101 | -18.8% ▼ | |
| Lercanidipine hydrochloride | 31 | 1,680 | £177 | -95.0% ▼ |
| Dutasteride | 31 | 1,440 | £82 | -39.6% ▼ |
| Verapamil hydrochloride | 30 | 1,512 | £144 | -66.9% ▼ |
| Temazepam | 30 | 715 | £629 | -47.6% ▼ |
| Dosulepin hydrochloride | 30 | 1,288 | £217 | -47.0% ▼ |
| Duloxetine hydrochloride | 30 | 1,736 | £424 | -41.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.